The MAPK/ERK signaling pathway is an additional essential target for inhibitors. Inhibitors targeting MAPK/ERK are employed in cancer cells therapies to avoid uncontrolled cell spreading and lump growth.Anti-infection inhibitors incorporate a wider range of agents that target numerous microorganisms such as viruses, fungi, and bloodsuckers. In the